Look at the latest from CNBC - 1 in 3 Covid survivors suffers neurological or mental disorders, study finds

Lockdowns will likely become a thing of the past once England emerges from restrictions in June, Professor Chris Whitty has said, as he suggested Britain will treat coronavirus like the flu in the future.

England’s chief medical officer said the UK would have to learn to live with the virus, noting that up to 25,000 people can die in a bad flu year without the figure hitting the headlines.

• Dr. Kate Clancy, a University of Illinois associate professor, said that she'd heard people had experienced changes in their menstruation since getting vaccinated
• Her tweet prompted other women to share changes to their own periods
• Several reported that they were bleeding more heavily and for longer than they had before getting the vaccine 

Research on SARS-CoV-2 RNA by scientists at Harvard and MIT has implications for how mRNA vaccines could permanently alter genomic DNA, according to Doug Corrigan, Ph.D., a biochemist-molecular biologist who says more research is needed.

The Astra-Zeneca "cheap and easy to store" "

 To compare the effect in the experimental group versus the control group, a test of comparison of proportions and their confidence intervals was performed for the general symptoms, and for the VAS and Likert criteria, a paired test using the Wilcoxon-Mann-Whitney test (α: 95%) was performed . When comparing the experimental group with the control group on the seventh day after symptom manifestation, a significant difference was found in the experimental group with respect to the control group for the symptoms Fever (p: 0000), Cough (p: 0.0000), Chills (p: 0.0000) and Dyspnea (p: 0.0006). When performing the visual analogous comparison of pain in the control group and in the experimental group, it was found that in all the items that make up the scale decreased significantly in this group with respect to the control group (p: 0.0000; p:00017). On day 14 post-demonstration the difference was greater (p:0.000 ; p:0.0043). When evaluating both groups (Control and Experimental) in the laboratories, a difference was found for the values of the parameters PC Reactive on day 7 (p: 0.0001) and DH Lactate (0.0036), with higher scores for the experimental group; Dimero-D on day 7 (p: 0.0194) and on day 14 (p:0.0029) ; difference was found in all parameters. The results overall (p <0.05) demonstrate the hypothesis that chlorine dioxide is effective in the treatment of COVID19.

Conclusion: Chlorine dioxide is effective in the treatment of COVID19 and the mechanisms of action by which it acts to achieve it are proposed in this work. We recommend doing more research. We recommend conducting double-blind studies and delving into studies of toxicological safety and therapeutic efficacy of chlorine dioxide in pathologies of epidemiological impact in the near future.